Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 207

Results For "development"

2926 News Found

Jubilant Ingrevia augments its CDMO presence with Rs 270 crore contract
Biotech | April 17, 2022

Jubilant Ingrevia augments its CDMO presence with Rs 270 crore contract

Through the contract, the company will supply two key GMP intermediates for one of the 'patented drugs' of the innovator pharmaceutical customer


Ashland expands distribution deal with Univar for pharma ingredients
News | April 15, 2022

Ashland expands distribution deal with Univar for pharma ingredients

Under the agreement, Univar Solutions customers in Brazil and Mexico will have access to Ashland's binders and disintegrants for solid dosage forms, matrix formers for modulated release drugs and coatings for regular and modulated release solid dosage forms


Juniper Biologics acquires cell-mediated gene therapy for treatment of knee osteoarthritis
Healthcare | April 13, 2022

Juniper Biologics acquires cell-mediated gene therapy for treatment of knee osteoarthritis

The US $600 million acquisition will see Juniper Biologics offer the world's first cell-mediated gene therapy to an estimated 300 million patients in Asia Pacific, Middle East and Africa


USFDA grants direct RMAT designation for the use of ExoFlo in Covid-19 related ARDS
Biotech | April 13, 2022

USFDA grants direct RMAT designation for the use of ExoFlo in Covid-19 related ARDS

An RMAT confers eligibility for accelerated approval and priority review of biologics licensing applications (BLA)


HanAll Biopharma and Daewoong Pharmaceutical Invest in Turn Biotechnologies
Biotech | April 13, 2022

HanAll Biopharma and Daewoong Pharmaceutical Invest in Turn Biotechnologies

Turn has developed a novel cell rejuvenating platform with significant potential for application in an array of age-related diseases


Shoreline Biosciences showcases novel methodology to produce clinical scale iPSC-derived NK (iNK) cells
Biotech | April 13, 2022

Shoreline Biosciences showcases novel methodology to produce clinical scale iPSC-derived NK (iNK) cells

Shoreline has developed a proprietary methodology to create differentiated iNK cells for large-scale, "off-the-shelf" production


Cloudbyz partners with ClinChoice to provide integrated clinical trial management solutions
Biotech | April 13, 2022

Cloudbyz partners with ClinChoice to provide integrated clinical trial management solutions

The joint partnership, powered by Cloudbyz Clinical Research Management Platform and ClinChoice's industry-leading transformation services, will provide an end-to-end clinical research management technology platform and services to customers


Pharmapack Europe 2022 to open on May 18-19 in Paris
Packaging | April 12, 2022

Pharmapack Europe 2022 to open on May 18-19 in Paris

Pharmapack trends are a key barometer of global device and packing opportunities in 2022


ReiThera and Exothera collaborate to develop large-scale, low cost per dose vaccine
Biotech | April 12, 2022

ReiThera and Exothera collaborate to develop large-scale, low cost per dose vaccine

Collaboration awarded €3 million grant by the Bill & Melinda Gates Foundation


Cambrex completes large-scale US API expansion
Biotech | April 12, 2022

Cambrex completes large-scale US API expansion

The expansion positions Cambrex with the largest and most advanced API facility in the United States